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Lipoxygenases (LOXs) catalyze the regiospecific and stereospecific dioxygena-
tion of polyunsaturated membrane-embedded fatty acids. A Ca2+-dependent
membrane-binding function was localized to the amino-terminal C2-like domain
of 8R-lipoxygenase (8R-LOX) from the soft coral Plexaura homomalla. The
3.2 Å crystal structure of 8R-LOX and spectroscopic data suggested that Ca2+
stabilizes two membrane-insertion loops. Analysis of the protein packing
contacts in the crystal lattice indicated that the conformation of one of the two
loops complicated efforts to improve the resolution of the X-ray data. A
deletion mutant of 8R-LOX in which the corresponding membrane-insertion
loop is absent (41–45:GSLOX) was engineered. Removal of the membrane-
insertion loop dramatically increases the protein yield from bacterial cultures
and the quality of the crystals obtained, resulting in a better than 1 Å
improvement in the resolution of the diffraction data.
1. Introduction
Owing to their pivotal roles in the biosynthesis of leukotrienes and
other biologically active eicosanoids, lipoxygenases (LOXs; Kuhn et
al., 2005; Brash, 1999) are targets for the development of specific
inhibitors to modulate the physiological and pathological effects of
these potent signalling compounds (Werz & Steinhilber, 2006;
Dahlen, 2006). The strict regiospecificity (reviewed in Schneider et al.,
2007) of the various lipoxygenases indicates that selective targeting of
a single LOX isozyme is feasible, a requisite feature of an effective
therapeutic strategy. The human isozyme 5-lipoxygenase (5-LOX)
catalyzes the first step in the synthesis of leukotriene bronchocon-
strictors and as such is a target for drugs to treat asthma. Lipox-
ygenases are iron enzymes and thus can be inhibited by iron chelators
or redox-active compounds. However, the redox mode of inhibition is
highly nonspecific and consequently replete with undesirable side
effects. In order to engineer specificity into novel inhibitors, structural
information that provides insight into substrate recognition is
required.
To date, the structures of the 15-lipoxygenase from rabbit
reticulocytes (Gillmor et al., 1997), an 8R-lipoxygenase from the soft
coral Plexaura homomalla (Oldham et al., 2005) and four plant
enzymes (Boyington et al., 1997; Minor et al., 1996; Skrzypczak-
Jankun et al., 1997; Youn et al., 2006) have been published. The plant
lipoxygenases have afforded a robust model system to understand
mechanistic aspects of this class of iron enzymes in the context of
high-resolution crystal structures. In addition, structures of the plant
enzymes have been determined in the absence and presence of a
substrate analog. However, there are fundamental differences in the
substrate-binding mode for the plant and animal enzymes, as the
counterparts of the amino acids that influence regiospecificity in
15-LOX are not positioned to do so in the plant enzymes
(Skrzypczak-Jankun et al., 2001). Furthermore, the plant enzymes are
200 amino acids larger than the animal enzymes and much of the
additional polypeptide is located near the putative entrance to the
catalytic site. Additional structures of animal lipoxygenases are
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required in order to understand substrate acquisition and reaction
specificity.
Currently, there is no structure of an animal lipoxygenase with
substrate that can illuminate the mechanisms of regiospecificity and
stereospecificity or at least provide a structural framework for the
design of experiments to determine such details. An obvious choice
for these studies would be human 5-LOX because of its role in the
synthesis of leukotrienes. However, human 5-LOX is notoriously
unstable, losing 50% of its activity within 10 h unless glutathione
reductase and superoxide dismutase are also present (Hammarberg et
al., 2001; Zhang et al., 1994). The coral 8R-LOX, on the other hand,
retains >95% of its activity after storage at 277 K for four months.
Furthermore, the coral enzyme has 41% sequence identity to
human 5-LOX. Importantly, no other human LOX isozyme is more
than 42% identical to 5-LOX. Furthermore, like 5-LOX, 8R-LOX is
targeted to membranes by Ca2+ (Chen & Funk, 2001; Kulkarni et al.,
2002; Oldham et al., 2005). The coral enzyme can provide a tractable
system with which to address the lack of a model for enzyme–
substrate recognition in animal lipoxygenases if a high-resolution
structure can be obtained.
The previously reported 3.2 Å structure of 8R-LOX was deter-
mined using crystals grown in the presence of 100 mM Ca2+ (PDB
code 2fnq; Oldham et al., 2005). Although this resolution is modest,
the quality of the data, as judged from isotropic diffraction and low
mosaicity, suggested that crystals that diffract to higher resolution
could be obtained. However, to date refinement of the crystallization
conditions has not resulted in improved crystal quality. Inspection of
the packing in the 8R-LOX crystals revealed that a putative
membrane-insertion loop might have been frustrating attempts to
obtain crystals which diffract to high resolution: bound Ca2+ appears
to stabilize this loop, which emanates from the C2-like domain. The
loop includes Trp41 and Phe42, which are wedged in a hydrophobic
cavity on the surface of a symmetry mate. This protein–protein
interaction appears to hold the symmetry mates at ‘arm’s length’ and
precludes additional contact points between neighboring molecules
that might involve stable elements of secondary structure. Further-
more, at the high concentration of protein necessary for crystal-
lization it is likely that this loop–protein interaction will dominate
protein–protein interactions even in the absence of Ca2+. The
inherent flexibility of an unstabilized loop would further limit crystal
quality, so elimination of Ca2+ from the crystallization conditions is
not likely to be an option. Therefore, a modified form of the enzyme
was constructed in which Trp41 and Phe42 were deleted. As
described below, the mutant enzyme was soluble, enzymatically active
in a membrane-free assay and yielded crystals that diffracted to 2.0 Å.
2. Materials and methods
2.1. Molecular biology
A pET-3a plasmid expressing 8R-LOX under control of the T7
promoter (Oldham et al., 2005) was used as the template for muta-
genesis. The entire plasmid was amplified by whole-plasmid poly-
merase chain reaction. Primers were designed to delete the sequence
between Lys40 and Phe46. Codons for glycine and serine were added
to the 50 ends of the forward and reverse primers, respectively. These
codons provided a restriction site that could be used to distinguish
between wild-type and mutant plasmids. Furthermore, Gly and Ser
are commonly found in reverse turns and should be readily accom-
modated in the shortened loop. Consequently, the amino-acid
sequence of the mutant protein between amino acids 40 and 46 was
changed from KWFHNDF to KGSF. Although coral 8R-LOX occurs
naturally as the C-terminal 683 amino acids of a 1066-amino-acid
bifunctional protein (Koljak et al., 1997), for ease of comparison to
animal lipoxygenases the residue-numbering convention used here
refers only to the LOX domain as in Oldham et al. (2005). Hence, the
mutant enzyme was designated 41–45:GSLOX.
2.2. Protein expression and purification
The 41–45:GSLOX construct in pET-3a was transformed into
Escherichia coli BL21(DE3) cells (Invitrogen). Colonies were picked
and grown overnight in 20 ml Luria broth at 310 K and then trans-
ferred into 500 ml of the auto-inducing medium ZYM-5052 (Studier,
2005). Cultures were grown at 293 K until the absorbance at 600 nm
was stable for 4 h. Cells were harvested by centrifugation and frozen
at 193 K. Cell pellets were resuspended in Bugbuster (Novagen)
along with DNase I and the protease inhibitors leupeptin and
pepstatin. The suspension was then sonicated and centrifuged. The
supernatant was applied onto Ni-bound chelating agarose (GE
Healthcare) and the column was washed extensively with binding
buffer (20 mM Tris pH 8, 500 mM NaCl). The protein was eluted with
an imidazole gradient (0–200 mM in binding buffer). Fractions were
checked for purity by SDS–PAGE and analyzed for activity as
described below. Further purification on a Mono-Q anion-exchange
(GE Healthcare) resin using a gradient of 0–500 mM NaCl in 20 mM
Tris pH 8, along with size-exclusion chromatography on Superdex-
200 (GE Healthcare) in 20 mM Tris pH 8, 150 mM NaCl, yielded
purified enzyme. Yields of 40 mg highly purified 41–45:GSLOX per
litre of culture were routinely obtained.
The enzymatic activity of 41–45:GSLOX in the absence and
presence of liposomes was monitored by following the absorbance of
product at 235 nm in an assay previously described by Oldham et al.
(2005). Measurements were performed in an Applied Photophysics
Ltd model SX17MV stopped-flow spectrometer.
2.3. Crystallization and data collection
Crystal screens based on the method of Jancarik & Kim (1991)
were performed to identify conditions that favored crystal growth.
Crystals of 41–45:GSLOX were obtained by vapor diffusion from
hanging drops (4 ml) containing a 1:1(v:v) ratio of protein solution to
reservoir solution. The reservoir solution contained 6–8%(w/v)
polyethylene glycol 8000, 5%(w/v) glycerol, 1%(w/v) Tween 20 and
200 mM CaCl2 in 100 mM imidazole acetate pH 8.0. Crystals formed
in approximately 24 h at 293 K in space group P21 (unit-cell para-
meters a = 104.0, b = 170.2, c = 104.5 Å,  = 95.9). With four
monomers per asymmetric unit, the solvent content was 57.8% and
the Matthews coefficient was 2.9 Å3 Da1 (Matthews, 1968). The
crystals were transferred to a cryobuffer consisting of 10% poly-
crystallization communications
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Table 1
Data-collection statistics of 41–45:GSLOX.
Space group P21
Unit-cell parameters (Å, ) a = 104.0, b = 170.2,
c = 104.5,  = 95.9
Monomers per ASU 4
Matthews coefficient (Å3 Da1) 2.9
Solvent content (%) 57
Diffraction limit (Å) 2.0
Resolution (Å) 30–2.00 (2.07–2.00)
Unique reflections 243328 (3259)
Rmerge† 0.058 (0.274)











i Ii , where Ii is the intensity of the ith observation of
reflection h and hIi is the mean intensity of the reflection from multiple observations.
ethylene glycol 8000, 30% glycerol, 1% Tween 20 and 20 mM CaCl2
in 100 mM imidazole acetate pH 8.0 and were immediately mounted
and flash-cooled in a stream of cold nitrogen gas (100 K). X-ray
diffraction data of 41–45:GSLOX were collected using a MAR165
CCD detector (MAR USA) on the Gulf Coast Protein Crystallo-
graphy Consortium-PX beamline at the Center for Advanced
Microstructures and Devices (CAMD, Baton Rouge, LA, USA).
Data-collection statistics are shown in Table 1.
3. Results and discussion
The membrane-binding properties of some animal lipoxygenases can
complicate efforts to obtain crystals that diffract to high resolution. In
the previously reported 8R-LOX structure (Oldham et al., 2005), a
putative Ca2+-stabilized hydrophobic membrane-insertion loop is
involved in a packing contact that appears to preclude lattice-
stabilizing protein–protein interactions (Fig. 1). The membrane-
insertion loop in question, which is common to the 8R- and 5-lip-
oxygenases, is not present in rabbit 15-lipoxygenase, for which a 2.4 Å
resolution structure has been determined (Gillmor et al., 1997). Its
absence in 15-LOX is an indication that the loop sequence is not
required for the structural integrity of the enzyme. The extended
structure of the membrane-insertion loop, combined with the fact
that an equivalent loop is not present in rabbit reticulocyte 15-LOX
(Fig. 2), led to the design and construction of an 8R-LOX mutant in
which the loop was absent. Because 41–45:GSLOX was soluble, a
yield of 40 mg purified protein per litre of culture was obtained. In
contrast, the bulk of the wild-type protein was in the insoluble frac-
tion and the yield of purified wild-type enzyme was only 8 mg per
litre of culture. The deletion-loop enzyme had 110% of the wild-type
activity in a liposome-free assay. In contrast, it displayed only 15% of
the activity of the native enzyme when assayed in the presence of
liposomes and Ca2+, conditions under which the enzyme must bind
membranes to access substrate. These results suggest that the loop
deletion disrupts the membrane-binding activity of the enzyme as
expected, but does not diminish its enzymatic activity.
A search of crystallization conditions with commercial screens
yielded conditions for optimization. Refinement of these initial
conditions, which were remarkably similar to those that produced the
crystals of wild-type enzyme (Oldham et al., 2005), yielded crystals
belonging to space group P21 that diffracted to 2.0 Å with a signal-to-
noise ratio of 5.7 in the highest shell. The wild-type crystals diffracted
to only 3.2 Å at the same X-ray source (CAMD), with a signal-to-
noise ratio that was no better than that reported for the rotating-
anode data (2.3 in the highest shell) of Oldham et al. (2005). Removal
of the extended membrane-binding loop resulted in greater than a
1.0 Å improvement in the resolution of the diffraction data.
The effects of the substitution of surface amino acids to improve
crystals of soluble proteins have previously been evaluated (D’Arcy
et al., 1999; Charron et al., 2002). In addition, protein engineering has
been applied to membrane-associated proteins for the purpose of
solubilization and crystallization. For example, the solubility of
eukaryotic cytochrome P450s was improved by the deletion of the
amino-terminal membrane-insertion helix (Scott et al., 2001) as well
as the mutation of an internal loop that plays a role in membrane
association (Cosme & Johnson, 2000; Hsu & Wang, 2003). However,
the length of the membrane-binding loop remained unchanged in the
engineered protein and in at least one case the enzyme activity was
compromised (Hsu & Wang, 2003).
The results presented here indicate that removal of a membrane-
insertion loop required for Ca2+-dependent membrane targeting of
8R-LOX improves the solubility of the protein, while the enzyme
activity in a membrane-free assay is unaffected (data not shown).
More importantly, the diffraction of crystals of 41–45:GSLOX is
significantly improved over that of wild-type crystals. While the
diffraction limit for the wild-type protein crystals was 3.2 Å, the
41–45:GSLOX crystals obtained under similar conditions diffract to
2.0 Å. Thus, removal of membrane-insertion loops, which can often
be predicted through multiple sequence alignment, should be a useful
crystallization communications
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Figure 1
Calcium ions (green) stabilize the membrane-binding loop that contains Trp41–
Phe42. Trp41 and Phe42 mediate a packing contact between symmetry mates (pink
and blue) in the crystal lattice (PDB code 2fnq).
Figure 2
Superposition of 8R-LOX (gray) on 15-LOX (PDB code 1lox; blue). The 8R-LOX
Ca2+-stabilized membrane-insertion loop containing the WF sequence is absent in
15-LOX (Ca2+, green).
strategy for increasing the probability of obtaining high-quality
crystals of Ca2+-dependent membrane-binding proteins.
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